Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The iBRA-2 (immediate breast reconstruction and adjuvant therapy audit) study: protocol for a prospective national multicentre cohort study to evaluate the impact of immediate breast reconstruction on the delivery of adjuvant therapy.
Dave R, O'Connell R, Rattay T, Tolkien Z, Barnes N, Skillman J, Williamson P, Conroy E, Gardiner M, Harnett A, O'Brien C, Blazeby J, Potter S, Holcombe C; Breast Reconstruction Research Collaborative. Dave R, et al. BMJ Open. 2016 Oct 7;6(10):e012678. doi: 10.1136/bmjopen-2016-012678. BMJ Open. 2016. PMID: 27855106 Free PMC article.
The impact of immediate breast reconstruction on the time to delivery of adjuvant therapy: the iBRA-2 study.
O'Connell RL, Rattay T, Dave RV, Trickey A, Skillman J, Barnes NLP, Gardiner M, Harnett A, Potter S, Holcombe C; iBRA-2 Steering Group; Breast Reconstruction Research Collaborative. O'Connell RL, et al. Among authors: dave rv. Br J Cancer. 2019 Apr;120(9):883-895. doi: 10.1038/s41416-019-0438-1. Epub 2019 Mar 29. Br J Cancer. 2019. PMID: 30923359 Free PMC article.
The NeST (neoadjuvant systemic therapy in breast cancer) study - Protocol for a prospective multi-centre cohort study to assess the current utilization and short-term outcomes of neoadjuvant systemic therapies in breast cancer.
Irwin GW, Bannon F, Coles CE, Copson E, Cutress RI, Dave RV, Grayson M, Holcombe C, Irshad S, O'Brien C, O'Connell RL, Palmieri C, Shaaban AM, Sharma N, Singh J, Whitehead I, Potter S, McIntosh SA. Irwin GW, et al. Among authors: dave rv. Int J Surg Protoc. 2019 Nov 11;18:5-11. doi: 10.1016/j.isjp.2019.10.002. eCollection 2019. Int J Surg Protoc. 2019. PMID: 31897446 Free PMC article.
Therapeutic mammaplasty is a safe and effective alternative to mastectomy with or without immediate breast reconstruction.
Potter S, Trickey A, Rattay T, O'Connell RL, Dave R, Baker E, Whisker L, Skillman J, Gardiner MD, Macmillan RD, Holcombe C; TeaM and iBRA-2 Steering Groups, the Breast Reconstruction Research Collaborative, and the Mammary Fold Academic and Research Collaborative. Potter S, et al. Br J Surg. 2020 Jun;107(7):832-844. doi: 10.1002/bjs.11468. Epub 2020 Feb 19. Br J Surg. 2020. PMID: 32073654
Breast cancer surgery during the COVID-19 pandemic.
Highton LR, Dave RV, Barnes NLP. Highton LR, et al. Among authors: dave rv. Br J Surg. 2020 Sep;107(10):e380. doi: 10.1002/bjs.11819. Epub 2020 Jul 20. Br J Surg. 2020. PMID: 32779735 Free PMC article. No abstract available.
The B-MaP-C study: Breast cancer management pathways during the COVID-19 pandemic. Study protocol.
Courtney A, O'Connell R, Rattay T, Kim B, Cutress RI, Kirwan CC, Gandhi A, Fairbrother P, Sharma N, Cartlidge CWJ, Horgan K, McIntosh SA, Leff DR, Vidya R, Potter S, Holcombe C, Copson E, Coles CE, Dave RV. Courtney A, et al. Among authors: dave rv. Int J Surg Protoc. 2020;24:1-5. doi: 10.1016/j.isjp.2020.07.003. Epub 2020 Jul 29. Int J Surg Protoc. 2020. PMID: 32838092 Free PMC article.
60 results